check_circleStudy Completed

Multiple Sclerosis

Bayer Identifier:

13853

ClinicalTrials.gov Identifier:

NCT00882453

EudraCT Number:

Not Available

EU CT Number:

Not Available
Physical activity and fatigue in early Multiple Sclerosis (MS)

Trial purpose

The purpose of this observational study is to obtain a survey on physical activity in patients who for the first time have experienced symptoms which indicate a high risk for developing multiple sclerosis (MS) and in patients with recently diagnosed MS, and to obtain information on factors potentially influencing the patients' level of activity.

Key Participants Requirements

Sex

Both

Age

18 - N/A
  • - Multiple sclerosis diagnosed within the last 12 months
    - Clinically isolated Syndrome (CIS), under Interferon-beta-1b treatment

Trial summary

Enrollment Goal
1739
Trial Dates
August 2006 - March 2011
Phase
N/A
Could I Receive a placebo
No
Products
Betaseron (Interferon beta-1b, BAY86-5046)
Accepts Healthy Volunteer
No

Where to participate

StatusInstitutionLocation
Completed
Many Locations, France
Completed
Many Locations, Spain
Completed
Many Locations, Canada
Completed
Many Locations, Netherlands
Completed
Many Locations, Sweden
Completed
Many Locations, Australia
Completed
Many Locations, Portugal
Completed
Many Locations, Greece
Completed
Many Locations, Korea, Republic Of
Completed
Many Locations, Taiwan
Completed
Many Locations, Thailand
Terminated
Many Locations, Egypt
Completed
Many Locations, Kazakhstan
Completed
Many Locations, Jordan
Completed
Many Locations, Lebanon
Completed
Many Locations, United Arab Emirates
Completed
Many Locations, Germany
Completed
Many Locations, United Kingdom
Completed
Many Locations, Italy
Completed
Many Locations, Belgium
Completed
Many Locations, Mexico
Completed
Many Locations, Denmark
Completed
Many Locations, Norway
Completed
Many Locations, Czech Republic
Completed
Many Locations, Israel
Completed
Many Locations, Austria
Completed
Many Locations, Colombia
Completed
Many Locations, Indonesia
Completed
Many Locations, Switzerland
Completed
Many Locations, Slovenia
Completed
Many Locations, Kuwait
Completed
Many Locations, Oman
Completed
Many Locations, Bahrain

Primary Outcome

  • Physical Activity and Fatigue
    date_rangeTime Frame:
    At baseline and at Month 24
    enhanced_encryption
    Safety Issue:
    No

Secondary Outcome

  • Health-related Quality of Life
    date_rangeTime Frame:
    At baseline and at Month 24
    enhanced_encryption
    Safety Issue:
    No
  • Depression
    date_rangeTime Frame:
    At baseline and at Month 24
    enhanced_encryption
    Safety Issue:
    No

Trial design

Betaferon treatment and Exercise data Gathering IN early MS
Trial Type
Observational
Intervention Type
Drug
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.